Having low lung function as a middle-aged smoker without airway obstruction raised the likelihood for all-cause mortality, ...

The FDA has approved Jascayd (nerandomilast) as a treatment for a second lung disease, progressive pulmonary fibrosis, following the drug’s initial approval in October 2025 as a treatment for ...

Pulmonary exacerbations are common in children with cystic fibrosis during the first 3 years of life and are associated with ...

Here are the top 5 most-read pulmonary fibrosis articles of 2025.

Just two months after reviving its prowess in the idiopathic pulmonary fibrosis (IPF) treatment area with rare lung disease med Jascayd, Boehringer Ingelheim is already unlocking another patient po | ...

Air pollution, particularly fine particulate matter (PM2.5), poses a major threat to our lungs, leading to health issues like ...

FDA Clears New Lung DrugThe US Food and Drug Administration has approved Jascayd (nerandomilast) tablets for adults with ...

When it comes to your health, what you put into your body goes a long way. That's no different for your lungs. If you’re concerned about warding off lung cancer, repairing any damage that you may have ...

Your lungs have a vital job: Every cell in your body needs oxygen, and they depend on your lungs to get it. That's why it's important not to take your lung health for granted, especially as your lung ...

New research has identified the mechanism by which air pollution damages the lungs’ self-cleaning system, leaving us vulnerable to infection. In doing so, it has also identified a way to reverse that ...

Progressive pulmonary fibrosis (PPF) is a life-threatening, progressive lung condition, causing a continuous decline in lung function.1,2 -- Affecting up to 100,000 people in the U.S. and up to 5.6 ...

The novel radiotracer ¹⁸F-FAPI-RGD in PET/CT scans shows potential for diagnosing ILD in connective tissue disease patients by highlighting fibroblast activation and tissue remodeling. Patients with ...